Clinical Trials

780 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT07609862 2026-05-27

A Phase Ib/II Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

92 enrolled

Phase 2 Active not recruiting

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05458297 2026-05-22

MK-2140-006

189 enrolled

Phase 1 Active not recruiting

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT07154901 2026-05-22

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

34 enrolled

Lymphoma, Follicular, Renal Insufficiency

NCT03460977 2026-05-20

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

453 enrolled

LymphoidThoracic

Lymphoma, Follicular, Recurrence, Small Cell Lung Carcinoma

NCT05826535 2026-05-20

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

270 enrolled

Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Disease Attributes

NCT06549595 2026-05-20

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

1,018 enrolled

Lymphoma, Follicular

NCT06911502 2026-05-20

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

400 enrolled

Phase NA Active not recruiting

Lymphoma, Follicular

NCT05149755 2026-05-19

Evolut™ EXPAND TAVR II Pivotal Trial

650 enrolled

Constriction, Pathologic, Lymphoma, Follicular

NCT06091254 2026-05-19

OLYMPIA-1

822 enrolled

Lymphoma, Follicular

NCT07011966 2026-05-19

ASV Therapy for Insomnia

Phase NA Recruiting

25 enrolled

Sleep Initiation and Maintenance Disorders, Lymphoma, Follicular

NCT07226843 2026-05-19

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

460 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07519772 2026-05-15

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

200 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT02362035 2026-05-13

KEYNOTE145

Phase 1/2 Completed

161 enrolled 29 charts

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT07101328 2026-05-13

BAF_FRontier-1

Phase 1 Not yet recruiting

215 enrolled

Phase 1 Active not recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05688475 2026-05-11

A Rollover Study of CC-122

12 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05919069 2026-05-11

A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693

Phase 1 Completed

35 enrolled

Lymphoma, Follicular

NCT07422610 2026-05-11

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

24 enrolled

Lymphoma, Follicular

NCT01804686 2026-05-08

CAN3001

700 enrolled

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT06149286 2026-05-06

OLYMPIA-5

470 enrolled

Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Marginal Zone

NCT06191744 2026-05-06

EPCORE™FL-2

1,095 enrolled

Phase 1/2 Active not recruiting

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT04542824 2026-05-05

EPCORE™ NHL-3

78 enrolled

Phase 1/2 Active not recruiting

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT04663347 2026-05-05

EPCORE™ NHL-2

543 enrolled

Phase 3 Active not recruiting

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT04712097 2026-05-05

Celestimo

478 enrolled

Phase NA Active not recruiting

Lymphoma, Follicular, Recurrence

NCT05637801 2026-05-05

HOPE

670 enrolled

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06785818 2026-05-05

Long-term Follow up Local Registry Study of Kymriah in South Korea

Recruiting

500 enrolled

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT07546760 2026-05-05

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

28 enrolled

Lymphoma, Follicular

NCT07249905 2026-05-04

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

180 enrolled

LymphoidSarcoma

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Dendritic Cell Sarcoma, Interdigitating

NCT06542250 2026-05-01

TITANium

174 enrolled

Phase 3 Not yet recruiting

Lymphoma, Follicular, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT07562022 2026-05-01

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

93 enrolled

Lymphoma, Follicular

NCT05156125 2026-04-30

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Phase 2 Terminated

213 enrolled 19 charts

Phase 4 Active not recruiting

Colitis, Ulcerative, Lymphoma, Follicular

NCT06752850 2026-04-30

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

37 enrolled

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT06784752 2026-04-30

NETTER-3

EndocrineGastrointestinalLymphoidNET

240 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

NCT07559474 2026-04-30

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Phase 1 Not yet recruiting

16 enrolled

Liver Diseases, Lymphoma, Follicular, Hepatic Insufficiency

NCT04594642 2026-04-29

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

227 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07282548 2026-04-29

Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies

Withdrawn

Lymphoma, Follicular

NCT05765812 2026-04-28

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Phase 1 Not yet recruiting

116 enrolled

CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT07550634 2026-04-24

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

32 enrolled

Phase 2/3 Active not recruiting

Lymphoma, Follicular, Hepatic Insufficiency

NCT06125951 2026-04-23

XanaMIA

247 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT07545603 2026-04-22

Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma

Phase 2 Recruiting

65 enrolled

Phase 3 Active not recruiting

Lymphoma, Follicular

NCT04224493 2026-04-20

SYMPHONY-1

555 enrolled

Lymphoma, Follicular

NCT06716814 2026-04-20

LIBERTY

Classical hematologyLymphoid

104 enrolled

Blood Coagulation Disorders, Hemophilia A, Lymphoma, Follicular, Coagulation Protein Disorders

NCT05294731 2026-04-17

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

146 enrolled

Phase 3 Active not recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05888493 2026-04-17

LEDA

109 enrolled

Lymphoma, Follicular, Recurrence

NCT05984147 2026-04-17

ASHA-1

40 enrolled

Lymphoma, Follicular, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04329728 2026-04-15

OPAL

144 enrolled

Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoproliferative Disorders, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, T-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05131022 2026-04-14

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

572 enrolled

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06544265 2026-04-14

SynKIR-310 for Relapsed/Refractory B-NHL